Esperion Therapeutics
ESPR
#6169
Rank
โ‚ฌ0.75 B
Marketcap
3,20ย โ‚ฌ
Share price
-1.58%
Change (1 day)
-2.73%
Change (1 year)

Esperion Therapeutics (ESPR) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ0.31 Billion

According to Esperion Therapeutics's latest financial reports the company's total assets are โ‚ฌ0.31 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Esperion Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ0.33 B77.48%
2023-12-31โ‚ฌ0.18 B-19.46%
2022-12-31โ‚ฌ0.23 B-31.4%
2021-12-31โ‚ฌ0.33 B17.32%
2020-12-31โ‚ฌ0.28 B50.03%
2019-12-31โ‚ฌ0.19 B52.66%
2018-12-31โ‚ฌ0.12 B-45.85%
2017-12-31โ‚ฌ0.23 B-0.67%
2016-12-31โ‚ฌ0.23 B-13.76%
2015-12-31โ‚ฌ0.27 B129.47%
2014-12-31โ‚ฌ0.11 B107.79%
2013-12-31โ‚ฌ56.69 M925.54%
2012-12-31โ‚ฌ5.52 M229.35%
2011-12-31โ‚ฌ1.67 M
2002-12-31โ‚ฌ49.17 M-44.56%
2001-12-31โ‚ฌ88.7 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ1.02 B 227.03%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ6.54 B 1,991.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ179.27 B 57,240.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ34.50 B 10,934.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ0.74 B 138.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚ฌ0.17 B-43.43%๐Ÿ‡บ๐Ÿ‡ธ USA